Patents by Inventor Beth D. Gudeman

Beth D. Gudeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Supercritical fluid extraction of bis-benzyl isoquinolines
    Patent number: 9745269
    Abstract: An improved process for obtaining at least one bis-benzyl isoquinoline alkaloid from botanical material involves contacting the botanical material with a supercritical fluid having as a major component one or more aliphatic hydrocarbon compounds, such as alkanes, alkenes, cyclic aliphatic hydrocarbons, or a combination of these compounds.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: August 29, 2017
    Inventor: Beth D. Gudeman
  • SUPERCRITICAL FLUID EXTRACTION OF BIS-BENZYL ISOQUINOLINES
    Publication number: 20150073151
    Abstract: An improved process for obtaining at least one bis-benzyl isoquinoline alkaloid from botanical material involves contacting the botanical material with a supercritical fluid having as a major component one or more aliphatic hydrocarbon compounds, such as alkanes, alkenes, cyclic aliphatic hydrocarbons, or a combination of these compounds.
    Type: Application
    Filed: March 12, 2014
    Publication date: March 12, 2015
    Applicant: CBA Pharma, Inc.
    Inventors: Beth D. Gudeman, Ram Murty
  • MDR METHOD AND PRODUCTS FOR TREATING MRSA
    Publication number: 20140073591
    Abstract: Multidrug resistance reversers of the d-tetrandrine family are used in conjunction with penicillins and other principle drugs used to treat MRSA.
    Type: Application
    Filed: September 12, 2013
    Publication date: March 13, 2014
    Applicant: CBA Pharma, Inc.
    Inventors: Wayne Michael Putnam, Beth D. Gudeman